The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice

Journal of Periodontal Research

Volumn 44, Issue 3, 2009, Pages 305-310

  Nishihara, R ^a   Sugano, N ^a   Takano, M ^a   Shimada, T ^a   Tanaka, H ^a   Oka, S ^a   Ito, K ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Adiponectin; Diabetes mellitus; Interleukin 6; Porphyromonas gingivalis; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; AUTACOID; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABSCESS; ANIMAL; ARTICLE; BACTEROIDACEAE INFECTION; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; MALE; MICROBIOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONOBESE DIABETIC MOUSE; PORPHYROMONAS GINGIVALIS; WOUND HEALING;

ABSCESS; ADIPONECTIN; ANIMALS; BACTEROIDACEAE INFECTIONS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PORPHYROMONAS GINGIVALIS; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 65349176489     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01130.x     Document Type: Article

References (35)

1. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993 16 : 329 334. (Pubitemid 23013872)
2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005 366 : 1809 1820. (Pubitemid 41642647)
3. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin -dependent diabetes mellitus. J Periodontol 1991 62 : 123 131.
4. Nelson RG, Shlossman M, Budding LM et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990 13 : 836 840. (Pubitemid 20331537)
5. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981 52 : 410 415.
6. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971 284 : 621 627.
7. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial. Am J Epidemiol 1996 144 : 537 547.
8. Nishimura F, Terranova V, Foo H, Kurihara M, Kurihara H, Murayama Y. Glucose-mediated alteration of cellular function in human periodontal ligament cells. J Dent Res 1996 75 : 1664 1671.
9. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol 2006 77 : 1289 1303.
10. Pucher J, Stewart J. Periodontal disease and diabetes mellitus. Curr Diab Rep 2004 4 : 46 50. (Pubitemid 39359510)
11. Iwamoto Y, Nishimura F, Nakagawa M et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001 72 : 774 778. (Pubitemid 33606560)
12. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007 34 : 835 843.
13. Graves DT. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 1999 28 : 482 490. (Pubitemid 29242521)
14. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998 25 : 134 144. (Pubitemid 128705944)
15. Iwatsuka H, Shino A, Suzuoki Z. General survey of diabetic features of yellow KK mice. Endocrinol Jpn 1970 17 : 23 35.
16. Leone CW, Bokhadhoor H, Kuo D et al. Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis. Infect Immun 2006 74 : 2286 2292.
17. Graves DT, Oskoui M, Volejnikova S et al. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 2001 80 : 1875 1879.
18. Tanner A, Kent R, Maiden MF, Taubman MA. Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. J Periodont Res 1996 31 : 195 204. (Pubitemid 126460204)
19. Duncan BB, Schmidt MI, Pankow JS et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003 52 : 1799 1805. (Pubitemid 36792473)
20. Desfaits AC, Serri O, Renier G. Nosrmalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care 1998 21 : 487 493. (Pubitemid 28172921)
21. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001 52 : 119 123. (Pubitemid 32366481)
22. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993 259 : 87 91. (Pubitemid 23036092)
23. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003 24 : 278 301. (Pubitemid 36724371)
24. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002 51 : 3391 3399. (Pubitemid 35403441)
25. Rosen BS, Cook KS, Yaglom J et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989 244 : 1483 1487. (Pubitemid 19171684)
26. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005 26 : 439 451. (Pubitemid 40686653)
27. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996 221 : 286 289. (Pubitemid 26136463)
28. Halleux CM, Takahashi M, Delporte ML et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001 288 : 1102 1107. (Pubitemid 33131713)
29. Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002 8 : 731 737. (Pubitemid 36305815)
30. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004 323 : 630 635. (Pubitemid 39221142)
31. Yokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 96 : 1723 1732. (Pubitemid 30661055)
32. Fasshauer M, Kralisch S, Klier M et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003 301 : 1045 1050. (Pubitemid 36279218)
33. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 : 2473 2476. (Pubitemid 30005109)
34. Kawanami K, Maemura K, Takeda N et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine- endothelial cell interactions. Biochem Biophys Res Commun 2004 314 : 415 419. (Pubitemid 38084733)
35. Oshima K, Nampei A, Matsuda M et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005 331 : 520 526. (Pubitemid 40602668)